The client is a US-headquartered publicly traded biopharmaceutical company. Its mission is to discover and deliver innovative medicines to solve today’s serious health issues and address tomorrow’s medical challenges. It strives to impact people’s lives across several critical therapeutic areas, including immunology, oncology, neuroscience, eye care, virology, women’s health, and gastroenterology.
The Challenge
The client was dependent on disparate platforms to develop and launch separate and new drugs. This resulted in siloed data which delayed the innovation process and time to market for new drugs. All those platforms were expensive and highly reliant on several third-party applications. The client had multiple systems with no integrated view of patient information. This resulted in a lack of proper coordination in patient management for the client’s outreach team. In line with their recent merger and acquisition activities, the client wanted to optimize business processes with the right technology solutions.
The Solution
Persistent developed an integrated platform on Salesforce to enable the client in launching multiple drug types from a single platform.
To make the integrated platform robust and comprehensive, Persistent leveraged the power of Salesforce Sales Cloud and Salesforce Service Cloud and added several operationally imperative features. The list of features included benefits investigation and verification, product, order, and territory management, patient assessment and survey, intake and knowledge management, an online reimbursement hub, and a multi-channel platform including not only digital but a telephone platform as well.
The Outcome
The solution reduced the existing 11 platforms to a single, integrated one for multi-drug launches. With this, the biopharmaceutical company now has a 360-degree view of patient data. The platform has also helped the client launch seven drugs and one-touch automation for intake and contact centers thereby reducing dependency on third-party products.
